Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human accelerated region 1, forward (HAR1F, also called HAR1A) is a long non-coding RNA gene identified as part of the human accelerated regions (HARs)—genomic segments that have evolved much faster in humans compared to other vertebrates[1][2][3]. HAR1F is specifically expressed in the developing human neocortex, a brain region associated with higher cognitive function in humans. Its transcript adopts a secondary structure that differs dramatically between humans and chimpanzees due to multiple human-specific nucleotide substitutions, suggesting possible human-specific function in brain development[1][2]. HAR1F is not protein-coding and lacks homology to other known RNA genes. To date, its precise biological function remains uncertain; it is not a defined therapeutic target, nor are there any drugs or biomarkers linked to it. Its discovery is notable for the potential role in the evolutionary development of the human brain, especially the neocortex[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human accelerated region 1, forward (non-coding RNA) (HAR1F).